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References
• Endonuclease Q (EndoQ) is a DNA repair enzyme 
originally identified in and isolated from euryarchaeon 
Pyrococcus furiosus (Pfu).1
• EndoQ recognizes a deaminated base or abasic site 
and cleaves the phosphodiester bond 5’ to the lesion.2
• APOBEC enzymes are cytosine deaminases; APOBEC3B 
(A3B) is shown to be upregulated in cancers.3
• BET is a potential inhibitor of A3B.4
• EndoQ efficiency depends on DNA substrate and is 
expected to act differently for different substrates and 
with addition of other enzymes (A3B, BET). Figure 1: S171A shows decreased efficiency compared to K15A and WT 
PfuEndoQ. Activity of 1μM WT and PfuEndoQ mutants (K15A, S1717A) 
with 200nM of different fluorescently labeled (FAM) oligonucleotide 
substrates is observed. Lanes 1-4 test EndoQ with dU:G substrate, lanes 
5-8 with dI:T substrate, and lanes 9-12 with dSpacer:T substrate.
Figure 2: Addition of BET is not shown to alter activity of A3B or effect 
EndoQ efficiency. 1μM PfuEndoQ (1-400) was used to test 1μM 
SUMO_A3B_DM activity with presence of SUMO_BET_FOAMV (30-482). 
Lanes 1-7 test with 100nM FAM-GT(C)A15 oligo and lanes 8-10 test with 
FAM-GT(dU)A15 oligo. BET buffer: [20μM TRIS (pH 7.4), 0.5 M NaCl, 5mM 
βMe]. 
• Activity of PfuEndoQ K15A appears to be 
comparable to WT EndoQ (Fig. 1).
• S171A PfuEndoQ mutant cleaves all three DNA 
substrates less efficiently than WT or K15A EndoQ 
(Fig.1).
• PfuEndoQ appears to cleave dSpacer:T substrate 
the most efficiently compared to dU:G or dI:T 
substrate (Fig. 1).
• Addition of BET is not shown to inhibit A3B or 
effect EndoQ efficiency (Fig. 2).
• Possible negative correlation between base-pair 
stability of DNA substrate and efficiency of EndoQ 
cleavage.
• Correlates with proposed EndoQ-DNA 
complex that suggests target base is 
flipped out from DNA and trapped by 
EndoQ during cleavage mechanism.4
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Future Directions
• Other PfuEndoQ variants, including rU and ssDNA 
substrates can be tested using this assay.
• This assay can be used to test known inhibitors of 
A3B: DNA containing 2’ deoxy-zebularine
(chemical cytosine deaminase inhibitor)5 or EBV 
protein factor BORF2.6
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